DCF — MCLEOD HEALTH CLARENDON
Enterprise Value: $-24.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-24.8M
Enterprise Value
$-9.1M
PV of Cash Flows
$-15.7M
PV of Terminal Value
$-25.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $53.5M | $-0.8M | -2.0% | $-3.1M | $-2.8M |
| Year 2 | $55.1M | $-0.3M | -1.0% | $-2.7M | $-2.2M |
| Year 3 | $56.7M | $0.2M | 0.0% | $-2.2M | $-1.6M |
| Year 4 | $58.4M | $0.5M | 1.0% | $-1.9M | $-1.3M |
| Year 5 | $60.2M | $0.7M | 1.0% | $-1.8M | $-1.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-24.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$51.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.02082926582100942
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5